0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fixed -point Mutation Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-37B17000
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Fixed point Mutation Service Market Research Report 2024
BUY CHAPTERS

Global Fixed -point Mutation Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-37B17000
Report
November 2025
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Fixed -point Mutation Service Market

The global Fixed -point Mutation Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Gene and Protein accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Fixed -point Mutation Service leading manufacturers including GenScript Biotech Corporation, Sangon Biotech (Shanghai) Co., Ltd., iGene Biotechnology Co., Ltd., Abace Biology, Zoonbio Biotechnology Co.,Ltd, etc., dominate supply; the top five capture approximately % of global revenue, with GenScript Biotech Corporation leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Fixed -point Mutation Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Fixed -point Mutation Service Market Report

Report Metric Details
Report Name Fixed -point Mutation Service Market
Segment by Type
  • Single -point Mutation
  • Multi -point Mutation
Segment by Application
  • Gene and Protein
  • DNA Vaccine and Antibody
  • Pharmaceutical
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GenScript Biotech Corporation, Sangon Biotech (Shanghai) Co., Ltd., iGene Biotechnology Co., Ltd., Abace Biology, Zoonbio Biotechnology Co.,Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Fixed -point Mutation Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Fixed -point Mutation Service Market report?

Ans: The main players in the Fixed -point Mutation Service Market are GenScript Biotech Corporation, Sangon Biotech (Shanghai) Co., Ltd., iGene Biotechnology Co., Ltd., Abace Biology, Zoonbio Biotechnology Co.,Ltd

What are the Application segmentation covered in the Fixed -point Mutation Service Market report?

Ans: The Applications covered in the Fixed -point Mutation Service Market report are Gene and Protein, DNA Vaccine and Antibody, Pharmaceutical, Others

What are the Type segmentation covered in the Fixed -point Mutation Service Market report?

Ans: The Types covered in the Fixed -point Mutation Service Market report are Single -point Mutation, Multi -point Mutation

1 Study Coverage
1.1 Introduction to Fixed -point Mutation Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Fixed -point Mutation Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single -point Mutation
1.2.3 Multi -point Mutation
1.3 Market Segmentation by Application
1.3.1 Global Fixed -point Mutation Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Gene and Protein
1.3.3 DNA Vaccine and Antibody
1.3.4 Pharmaceutical
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fixed -point Mutation Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Fixed -point Mutation Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Fixed -point Mutation Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Fixed -point Mutation Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Single -point Mutation Market Size by Players
3.3.2 Multi -point Mutation Market Size by Players
3.4 Global Fixed -point Mutation Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Fixed -point Mutation Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Fixed -point Mutation Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Fixed -point Mutation Service Market Size by Type (2020-2031)
6.4 North America Fixed -point Mutation Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Fixed -point Mutation Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Fixed -point Mutation Service Market Size by Type (2020-2031)
7.4 Europe Fixed -point Mutation Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Fixed -point Mutation Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Fixed -point Mutation Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Fixed -point Mutation Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Fixed -point Mutation Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Fixed -point Mutation Service Market Size by Type (2020-2031)
9.4 Central and South America Fixed -point Mutation Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Fixed -point Mutation Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Fixed -point Mutation Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Fixed -point Mutation Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Fixed -point Mutation Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 GenScript Biotech Corporation
11.1.1 GenScript Biotech Corporation Corporation Information
11.1.2 GenScript Biotech Corporation Business Overview
11.1.3 GenScript Biotech Corporation Fixed -point Mutation Service Product Features and Attributes
11.1.4 GenScript Biotech Corporation Fixed -point Mutation Service Revenue and Gross Margin (2020-2025)
11.1.5 GenScript Biotech Corporation Fixed -point Mutation Service Revenue by Product in 2024
11.1.6 GenScript Biotech Corporation Fixed -point Mutation Service Revenue by Application in 2024
11.1.7 GenScript Biotech Corporation Fixed -point Mutation Service Revenue by Geographic Area in 2024
11.1.8 GenScript Biotech Corporation Fixed -point Mutation Service SWOT Analysis
11.1.9 GenScript Biotech Corporation Recent Developments
11.2 Sangon Biotech (Shanghai) Co., Ltd.
11.2.1 Sangon Biotech (Shanghai) Co., Ltd. Corporation Information
11.2.2 Sangon Biotech (Shanghai) Co., Ltd. Business Overview
11.2.3 Sangon Biotech (Shanghai) Co., Ltd. Fixed -point Mutation Service Product Features and Attributes
11.2.4 Sangon Biotech (Shanghai) Co., Ltd. Fixed -point Mutation Service Revenue and Gross Margin (2020-2025)
11.2.5 Sangon Biotech (Shanghai) Co., Ltd. Fixed -point Mutation Service Revenue by Product in 2024
11.2.6 Sangon Biotech (Shanghai) Co., Ltd. Fixed -point Mutation Service Revenue by Application in 2024
11.2.7 Sangon Biotech (Shanghai) Co., Ltd. Fixed -point Mutation Service Revenue by Geographic Area in 2024
11.2.8 Sangon Biotech (Shanghai) Co., Ltd. Fixed -point Mutation Service SWOT Analysis
11.2.9 Sangon Biotech (Shanghai) Co., Ltd. Recent Developments
11.3 iGene Biotechnology Co., Ltd.
11.3.1 iGene Biotechnology Co., Ltd. Corporation Information
11.3.2 iGene Biotechnology Co., Ltd. Business Overview
11.3.3 iGene Biotechnology Co., Ltd. Fixed -point Mutation Service Product Features and Attributes
11.3.4 iGene Biotechnology Co., Ltd. Fixed -point Mutation Service Revenue and Gross Margin (2020-2025)
11.3.5 iGene Biotechnology Co., Ltd. Fixed -point Mutation Service Revenue by Product in 2024
11.3.6 iGene Biotechnology Co., Ltd. Fixed -point Mutation Service Revenue by Application in 2024
11.3.7 iGene Biotechnology Co., Ltd. Fixed -point Mutation Service Revenue by Geographic Area in 2024
11.3.8 iGene Biotechnology Co., Ltd. Fixed -point Mutation Service SWOT Analysis
11.3.9 iGene Biotechnology Co., Ltd. Recent Developments
11.4 Abace Biology
11.4.1 Abace Biology Corporation Information
11.4.2 Abace Biology Business Overview
11.4.3 Abace Biology Fixed -point Mutation Service Product Features and Attributes
11.4.4 Abace Biology Fixed -point Mutation Service Revenue and Gross Margin (2020-2025)
11.4.5 Abace Biology Fixed -point Mutation Service Revenue by Product in 2024
11.4.6 Abace Biology Fixed -point Mutation Service Revenue by Application in 2024
11.4.7 Abace Biology Fixed -point Mutation Service Revenue by Geographic Area in 2024
11.4.8 Abace Biology Fixed -point Mutation Service SWOT Analysis
11.4.9 Abace Biology Recent Developments
11.5 Zoonbio Biotechnology Co.,Ltd
11.5.1 Zoonbio Biotechnology Co.,Ltd Corporation Information
11.5.2 Zoonbio Biotechnology Co.,Ltd Business Overview
11.5.3 Zoonbio Biotechnology Co.,Ltd Fixed -point Mutation Service Product Features and Attributes
11.5.4 Zoonbio Biotechnology Co.,Ltd Fixed -point Mutation Service Revenue and Gross Margin (2020-2025)
11.5.5 Zoonbio Biotechnology Co.,Ltd Fixed -point Mutation Service Revenue by Product in 2024
11.5.6 Zoonbio Biotechnology Co.,Ltd Fixed -point Mutation Service Revenue by Application in 2024
11.5.7 Zoonbio Biotechnology Co.,Ltd Fixed -point Mutation Service Revenue by Geographic Area in 2024
11.5.8 Zoonbio Biotechnology Co.,Ltd Fixed -point Mutation Service SWOT Analysis
11.5.9 Zoonbio Biotechnology Co.,Ltd Recent Developments
12 Fixed -point Mutation ServiceIndustry Chain Analysis
12.1 Fixed -point Mutation Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Fixed -point Mutation Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Fixed -point Mutation Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Fixed -point Mutation Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Fixed -point Mutation Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Fixed -point Mutation Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Fixed -point Mutation Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Fixed -point Mutation Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Fixed -point Mutation Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Fixed -point Mutation Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Fixed -point Mutation Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fixed -point Mutation Service as of 2024)
 Table 11. Global Fixed -point Mutation Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Fixed -point Mutation Service Companies Headquarters
 Table 13. Global Fixed -point Mutation Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Fixed -point Mutation Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Fixed -point Mutation Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Fixed -point Mutation Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Fixed -point Mutation Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Fixed -point Mutation Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Fixed -point Mutation Service Growth Accelerators and Market Barriers
 Table 25. North America Fixed -point Mutation Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Fixed -point Mutation Service Growth Accelerators and Market Barriers
 Table 27. Europe Fixed -point Mutation Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Fixed -point Mutation Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Fixed -point Mutation Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Fixed -point Mutation Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Fixed -point Mutation Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Fixed -point Mutation Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Fixed -point Mutation Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. GenScript Biotech Corporation Corporation Information
 Table 35. GenScript Biotech Corporation Description and Major Businesses
 Table 36. GenScript Biotech Corporation Product Features and Attributes
 Table 37. GenScript Biotech Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. GenScript Biotech Corporation Revenue Proportion by Product in 2024
 Table 39. GenScript Biotech Corporation Revenue Proportion by Application in 2024
 Table 40. GenScript Biotech Corporation Revenue Proportion by Geographic Area in 2024
 Table 41. GenScript Biotech Corporation Fixed -point Mutation Service SWOT Analysis
 Table 42. GenScript Biotech Corporation Recent Developments
 Table 43. Sangon Biotech (Shanghai) Co., Ltd. Corporation Information
 Table 44. Sangon Biotech (Shanghai) Co., Ltd. Description and Major Businesses
 Table 45. Sangon Biotech (Shanghai) Co., Ltd. Product Features and Attributes
 Table 46. Sangon Biotech (Shanghai) Co., Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Sangon Biotech (Shanghai) Co., Ltd. Revenue Proportion by Product in 2024
 Table 48. Sangon Biotech (Shanghai) Co., Ltd. Revenue Proportion by Application in 2024
 Table 49. Sangon Biotech (Shanghai) Co., Ltd. Revenue Proportion by Geographic Area in 2024
 Table 50. Sangon Biotech (Shanghai) Co., Ltd. Fixed -point Mutation Service SWOT Analysis
 Table 51. Sangon Biotech (Shanghai) Co., Ltd. Recent Developments
 Table 52. iGene Biotechnology Co., Ltd. Corporation Information
 Table 53. iGene Biotechnology Co., Ltd. Description and Major Businesses
 Table 54. iGene Biotechnology Co., Ltd. Product Features and Attributes
 Table 55. iGene Biotechnology Co., Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. iGene Biotechnology Co., Ltd. Revenue Proportion by Product in 2024
 Table 57. iGene Biotechnology Co., Ltd. Revenue Proportion by Application in 2024
 Table 58. iGene Biotechnology Co., Ltd. Revenue Proportion by Geographic Area in 2024
 Table 59. iGene Biotechnology Co., Ltd. Fixed -point Mutation Service SWOT Analysis
 Table 60. iGene Biotechnology Co., Ltd. Recent Developments
 Table 61. Abace Biology Corporation Information
 Table 62. Abace Biology Description and Major Businesses
 Table 63. Abace Biology Product Features and Attributes
 Table 64. Abace Biology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Abace Biology Revenue Proportion by Product in 2024
 Table 66. Abace Biology Revenue Proportion by Application in 2024
 Table 67. Abace Biology Revenue Proportion by Geographic Area in 2024
 Table 68. Abace Biology Fixed -point Mutation Service SWOT Analysis
 Table 69. Abace Biology Recent Developments
 Table 70. Zoonbio Biotechnology Co.,Ltd Corporation Information
 Table 71. Zoonbio Biotechnology Co.,Ltd Description and Major Businesses
 Table 72. Zoonbio Biotechnology Co.,Ltd Product Features and Attributes
 Table 73. Zoonbio Biotechnology Co.,Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Zoonbio Biotechnology Co.,Ltd Revenue Proportion by Product in 2024
 Table 75. Zoonbio Biotechnology Co.,Ltd Revenue Proportion by Application in 2024
 Table 76. Zoonbio Biotechnology Co.,Ltd Revenue Proportion by Geographic Area in 2024
 Table 77. Zoonbio Biotechnology Co.,Ltd Fixed -point Mutation Service SWOT Analysis
 Table 78. Zoonbio Biotechnology Co.,Ltd Recent Developments
 Table 79. Raw Materials Key Suppliers
 Table 80. Distributors List
 Table 81. Market Trends and Market Evolution
 Table 82. Market Drivers and Opportunities
 Table 83. Market Challenges, Risks, and Restraints
 Table 84. Research Programs/Design for This Report
 Table 85. Key Data Information from Secondary Sources
 Table 86. Key Data Information from Primary Sources


List of Figures
 Figure 1. Fixed -point Mutation Service Product Picture
 Figure 2. Global Fixed -point Mutation Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Single -point Mutation Product Picture
 Figure 4. Multi -point Mutation Product Picture
 Figure 5. Global Fixed -point Mutation Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Gene and Protein
 Figure 7. DNA Vaccine and Antibody
 Figure 8. Pharmaceutical
 Figure 9. Others
 Figure 10. Fixed -point Mutation Service Report Years Considered
 Figure 11. Global Fixed -point Mutation Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Fixed -point Mutation Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Fixed -point Mutation Service Revenue Market Share by Region (2020-2031)
 Figure 15. Global Fixed -point Mutation Service Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Single -point Mutation Revenue Market Share by Player in 2024
 Figure 18. Multi -point Mutation Revenue Market Share by Player in 2024
 Figure 19. Global Fixed -point Mutation Service Revenue Market Share by Type (2020-2031)
 Figure 20. Global Fixed -point Mutation Service Revenue Market Share by Application (2020-2031)
 Figure 21. North America Fixed -point Mutation Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 22. North America Top 5 Players Fixed -point Mutation Service Revenue (US$ Million) in 2024
 Figure 23. North America Fixed -point Mutation Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 24. North America Fixed -point Mutation Service Revenue (US$ Million) by Application (2020-2031)
 Figure 25. US Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 26. Canada Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 27. Mexico Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 28. Europe Fixed -point Mutation Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Europe Top 5 Players Fixed -point Mutation Service Revenue (US$ Million) in 2024
 Figure 30. Europe Fixed -point Mutation Service Revenue (US$ Million) by Type (2020-2031)
 Figure 31. Europe Fixed -point Mutation Service Revenue (US$ Million) by Application (2020-2031)
 Figure 32. Germany Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 33. France Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 34. U.K. Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 35. Italy Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 36. Russia Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Fixed -point Mutation Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Top 8 Players Fixed -point Mutation Service Revenue (US$ Million) in 2024
 Figure 39. Asia-Pacific Fixed -point Mutation Service Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Asia-Pacific Fixed -point Mutation Service Revenue (US$ Million) by Application (2020-2031)
 Figure 41. Indonesia Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 42. Japan Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 43. South Korea Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 44. Australia Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 45. India Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 46. Indonesia Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 47. Vietnam Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 48. Malaysia Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Philippines Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Singapore Fixed -point Mutation Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Central and South America Fixed -point Mutation Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Central and South America Top 5 Players Fixed -point Mutation Service Revenue (US$ Million) in 2024
 Figure 53. Central and South America Fixed -point Mutation Service Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Central and South America Fixed -point Mutation Service Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Brazil Fixed -point Mutation Service Revenue (2020-2025) & (US$ Million)
 Figure 56. Argentina Fixed -point Mutation Service Revenue (2020-2025) & (US$ Million)
 Figure 57. Middle East and Africa Fixed -point Mutation Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Top 5 Players Fixed -point Mutation Service Revenue (US$ Million) in 2024
 Figure 59. South America Fixed -point Mutation Service Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Middle East and Africa Fixed -point Mutation Service Revenue (US$ Million) by Application (2020-2031)
 Figure 61. GCC Countries Fixed -point Mutation Service Revenue (2020-2025) & (US$ Million)
 Figure 62. Israel Fixed -point Mutation Service Revenue (2020-2025) & (US$ Million)
 Figure 63. Egypt Fixed -point Mutation Service Revenue (2020-2025) & (US$ Million)
 Figure 64. South Africa Fixed -point Mutation Service Revenue (2020-2025) & (US$ Million)
 Figure 65. Fixed -point Mutation Service Industry Chain Mapping
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart